|
Volumn 91, Issue 4, 2016, Pages 33-51
|
Malaria vaccine: WHO position paper-January 2016
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MALARIA VACCINE;
COST BENEFIT ANALYSIS;
HUMAN;
IMMUNOLOGY;
INFANT;
INNATE IMMUNITY;
MALARIA, FALCIPARUM;
PHASE 3 CLINICAL TRIAL (TOPIC);
PLASMODIUM FALCIPARUM;
WORLD HEALTH ORGANIZATION;
CLINICAL TRIALS, PHASE III AS TOPIC;
COST-BENEFIT ANALYSIS;
HUMANS;
IMMUNITY, INNATE;
INFANT;
MALARIA VACCINES;
MALARIA, FALCIPARUM;
PLASMODIUM FALCIPARUM;
WORLD HEALTH ORGANIZATION;
|
EID: 84956925518
PISSN: 00498114
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (92)
|
References (0)
|